Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Charles River Laboratories International, Inc. CRL and Valo Health, Inc. recently announced an advanced product candidate for the treatment of different forms of lupus and other autoimmune indications ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...

Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Medicare covers lupus treatment in different ways depending on your age and how the condition affects you. Read more.

African Americans, particularly women, and residents of Southern states face disproportionately high rates of SLE-related mortality.

Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...